Opening stock page...
Fetching company snapshot, pricing, and intelligence.
Intelligence coverage: 60%
Basic profile, financials, and market data are shown below. Deep research is building in the background.
AI confidence 70% · refreshes every 15s during session
Zenas BioPharma, Inc. shows recovering business momentum based on AlphaOS pipeline evidence.
3 signals not yet derived from pipeline evidence
Pipeline evidence · 0d ago
ZBIO's AlphaOS Signals
Upgrade to Pro for validated historical pattern analysis on ZBIO.
Free accounts see more of this; Premium sees all of it.
Updated
What happened recently for Zenas BioPharma, Inc. (ZBIO) — events, not interpretation.
Research & analysis only — not investment advice.
Held in ETFsweight · est. sleeve dollars
Investment snapshot
ZBIO's AI investment thesis
Upgrade to Premium for ZBIO's full multi-agent investment thesis.
Free accounts see more of this; Premium sees all of it.
Unified data coverage and cross-signal highlights — market, SEC, earnings, opportunity
Strengthen intelligence
Latest price
$29.63
Market cap
$1.93B
Profitable
No
Revenue $10.00M
Net income
$-377.74M
FY Dec 31, 2025
Loading Wall Street consensus…
Loading earnings intelligence…
Building technical intelligence snapshot — check back shortly.
Loading market context…
No price history. Sync market data to load charts.
Loading SEC filing intelligence…
No filings ingested yet.
Investment Snapshot above is the primary AlphaOS analysis for Zenas BioPharma, Inc. — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.
Research & analysis only — not investment advice. Price, charts, and filings are above.
Follow Zenas BioPharma, Inc. through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.
Connected companies and research pages from the AlphaOS knowledge graph.